AYUSH- 64: A potential therapeutic agent in COVID-19
Corona Virus disease (COVID-19) has become a global pandemic resulting in large scale morbidity and mortality worldwide. The management of COVID-19 has been a big challenge because of multifactorial pathophysiology and no specific treatment. AYUSH-64, a poly-herbal formulation developed by CCRAS, Mi...
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Elsevier
2022-04-01
|
| Sarja: | Journal of Ayurveda and Integrative Medicine |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S0975947621002278 |